Blockchain Registration Transaction Record

Med-X Prepares for NASDAQ Listing and Offers Private Investment Opportunity

Med-X, the parent company of Nature-Cide, Malibu Brands, and Thermal-Aid, is planning a NASDAQ listing in the near future and offering private investors an opportunity to join them. Med-X has achieved 200% revenue growth in the last few years and is positioned at the forefront of the $17.6 billion biopesticides market. Learn more about Med-X and their investment opportunity here.

This news matters because it highlights the global expansion and NASDAQ listing plans of Med-X, a leader in green technology manufacturing. The company's commitment to providing natural solutions that reduce health risks and minimize harm to the environment not only benefits consumers and communities but also their shareholders and partners. The private investment opportunity before the NASDAQ listing presents a timely chance for investors to join a company with significant growth potential in the sustainable pest control market.